Engelson Erik T.

Chairman & CEO

C-suiteM

US·SEC (Form 4)

Lucira Health, Inc.

0

Total declarations

0

Company

€96,370

▲ Purchases (2 ops.)

—

▼ Sales (0 ops.)

Discover the complete record of transactions filed by Engelson Erik T., Chairman & CEO. Insider active across 1 companies, notably Lucira Health, Inc.. Aggregated, 2 disclosures have been logged. Total volume traded: €96k. The latest transaction was disclosed on 16 June 2022 — Acquisition. Regulator: SEC (Form 4). All data is free.

Declarations2 total

Executives▲PurchaseLLucira Health, Inc.29SEC

E

Engelson Erik T.President and Chief Executive

€14,12710,000 shares@ €1.412714.7% of flow

Common Stock

SEC:0001209191-22-038116:0·16 Jun 2022

Ideal exit: 13 Mar 2023 (T+270)

SEC ↗

Executives▲PurchaseLLucira Health, Inc.34SEC

E

Engelson Erik T.President and Chief Executive

€82,24330,000 shares@ €2.741485.3% of flow

Common Stock

SEC:0001209191-22-019327:0·15 Mar 2022

Ideal exit: 10 Dec 2022 (T+270)

SEC ↗

2 of 2 declarations

About Engelson Erik T.

Erik T. Engelson serves as the President and Chief Executive of Lucira Health, Inc. In this role, he oversees the company's operations and is responsible for the overall strategy. With significant experience in the healthcare sector, he plays a key role in business development and innovation. His leadership is crucial for the success of Lucira Health.